Premarket Mover Reneo Pharmaceuticals Inc Down 4.93 percent - InvestorsObserver

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Premarket Mover Reneo Pharmaceuticals Inc Down 4.93 InvestorsObserver

Read at news.google.com
Google News at Macroaxis
  

Reneo Pharmaceuticals Fundamental Analysis

We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Reneo Pharmaceuticals is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Reneo Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Reneo Pharmaceuticals Related Equities

CNSPCns Pharmaceuticals   5.45   
0%
100.0%
PRMEPrime Medicine,   5.07   
0%
93.0%
CGEMCullinan Oncology   3.99   
0%
73.0%
CELCCelcuity LLC   2.79   
0%
51.0%
CCCCC4 Therapeutics   2.58   
0%
47.0%
NKTXNkarta   2.55   
0%
46.0%
KZRKezar Life   2.13   
0%
39.0%
HOWLWerewolf Therapeutics   1.95   
0%
35.0%
RPRXRoyalty Pharma   0.67   
0%
12.0%
ADPTAdaptive Biotechnologies   0.00   
0%
0%
SMMTSummit Therapeutics   0.00   
0%
0%
LEGNLegend Biotech   0.06   
1.0%
0%
HEPAHepion Pharmaceuticals   0.20   
3.0%
0%
VIRVir Biotechnology   0.41   
7.0%
0%
IMMXImmix Biopharma   0.92   
16.0%
0%
DNAGinkgo Bioworks   0.95   
17.0%
0%
APLSApellis Pharmaceuticals   1.11   
20.0%
0%
EWTXEdgewise Therapeutics   1.20   
22.0%
0%
KRONKronos Bio   3.16   
57.0%
0%
OCEAOcean Biomedical   3.22   
59.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Reneo Stock

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance